IL6 and polycystic ovary syndrome: The findings from this study, particularly the differentiation between PCOS patients with and without insulin resistance, underscore the critical role of IL-6 as an inflammatory mediator and highlight the multifactorial aspects inherent in the pathophysiology of PCOS.